BiotechTube
Home/Ventyx Biosciences/William J. Sandborn, M.D.
WJ

William J. Sandborn, M.D.

Former Chief Medical Officer

Ventyx Biosciences

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesNeurodegenerative Diseases

Ventyx Biosciences Pipeline

DrugIndicationPhase
VTX002Ulcerative ColitisPhase 2
VTX2735Systemic Inflammatory DiseasesPhase 1
VTX3232CNS / Neuroinflammatory DiseasesPreclinical/Phase 1

Leadership Team at Ventyx Biosciences

RM
Raju Mohan, Ph.D.
Founder and former CEO
JG
John G. O'Gorman
Former Chief Financial Officer
CK
Christopher Krueger, Ph.D.
Former Chief Scientific Officer
View full Ventyx Biosciences profile